FI921875L - Foerfarande foer framstaellning av bensisotiazol- och bensisoxazol-3-karboxamider, vilka aer anvaendbara som laekemedel - Google Patents

Foerfarande foer framstaellning av bensisotiazol- och bensisoxazol-3-karboxamider, vilka aer anvaendbara som laekemedel Download PDF

Info

Publication number
FI921875L
FI921875L FI921875A FI921875A FI921875L FI 921875 L FI921875 L FI 921875L FI 921875 A FI921875 A FI 921875A FI 921875 A FI921875 A FI 921875A FI 921875 L FI921875 L FI 921875L
Authority
FI
Finland
Prior art keywords
carboxamider
bensisoxazol
bensisotiazol
och
foerfarande foer
Prior art date
Application number
FI921875A
Other languages
English (en)
Finnish (fi)
Other versions
FI921875A0 (fi
FI921875A7 (fi
Inventor
Nicholas J Hrib
John G Jurcak
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI921875A0 publication Critical patent/FI921875A0/fi
Publication of FI921875L publication Critical patent/FI921875L/fi
Publication of FI921875A7 publication Critical patent/FI921875A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI921875A 1991-04-29 1992-04-27 Menetelmä lääkeaineina käyttökelpoisten bentsisotiatsoli- ja bentsisoksatsoli-3-karboksiamidien valmistamiseksi FI921875A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90/002891A US5143923B1 (en) 1991-04-29 1991-04-29 Benzoisothiazole-and benzisoxazole-3-carboxamides

Publications (3)

Publication Number Publication Date
FI921875A0 FI921875A0 (fi) 1992-04-27
FI921875L true FI921875L (fi) 1992-10-30
FI921875A7 FI921875A7 (fi) 1992-10-30

Family

ID=24783602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921875A FI921875A7 (fi) 1991-04-29 1992-04-27 Menetelmä lääkeaineina käyttökelpoisten bentsisotiatsoli- ja bentsisoksatsoli-3-karboksiamidien valmistamiseksi

Country Status (21)

Country Link
US (1) US5143923B1 (cs)
EP (1) EP0511610B1 (cs)
JP (1) JP2656189B2 (cs)
KR (1) KR100215345B1 (cs)
AT (1) ATE142628T1 (cs)
AU (1) AU644054B2 (cs)
CA (1) CA2067404C (cs)
CZ (1) CZ282764B6 (cs)
DE (1) DE69213544T2 (cs)
DK (1) DK0511610T3 (cs)
ES (1) ES2094843T3 (cs)
FI (1) FI921875A7 (cs)
GR (1) GR3021211T3 (cs)
HU (1) HU214032B (cs)
IE (1) IE77036B1 (cs)
IL (1) IL101700A (cs)
MX (1) MX9201963A (cs)
NO (1) NO180488C (cs)
NZ (1) NZ242479A (cs)
PL (2) PL168090B1 (cs)
RU (1) RU2039057C1 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
US5240927A (en) * 1992-05-19 1993-08-31 Hoechst-Roussel Pharmaceuticals Incorporated Benzo[β]thiophen-3-yl piperazines as antipsychotic agents
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
GB9302622D0 (en) * 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
GB9603457D0 (cs) * 1996-02-19 1996-04-17 Merck & Co Inc
KR100242675B1 (ko) * 1995-02-28 2000-03-02 피터슨 존 메이달 4-아미노테트라히드로벤즈 이소옥사졸 또는 -이소티아졸 화합물
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
GB9716101D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Fused heterocyclic compounds
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
EP1131291B1 (en) * 1998-11-17 2004-10-20 F. Hoffmann-La Roche Ag 4-aroyl-piperidin-ccr-3 receptor antagonists iii
BR9915735A (pt) 1998-11-20 2001-09-04 Hoffmann La Roche Antagonistas receptores de ccr-3 de piperidina
US6518286B1 (en) 1999-03-26 2003-02-11 Astrazeneca Ab Compounds
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
AU5919001A (en) 2000-04-28 2001-11-12 Acadia Pharm Inc Muscarinic agonists
EP1535912A1 (en) * 2000-04-28 2005-06-01 Arcadia Pharmaceuticals Inc. Muscarinic agonists
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
ATE313534T1 (de) 2001-02-16 2006-01-15 Aventis Pharma Inc Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
US6770659B2 (en) * 2002-08-26 2004-08-03 Sk Corporation Benzoyl piperidine compounds
CA2498936C (en) * 2002-09-14 2013-02-12 Gov't Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Structurally rigid dopamine d3 receptor selective ligands and process for making them
EP1546143A1 (en) * 2002-09-17 2005-06-29 Warner-Lambert Company LLC Heterocyclic substituted piperazines for the treatment of schizophrenia
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
MXPA06004304A (es) * 2003-10-24 2006-06-05 Hoffmann La Roche Antagonistas del receptor ccr-3.
TWI374137B (en) * 2004-09-28 2012-10-11 Huntsman Adv Mat Switzerland Organic compounds
US20160296146A9 (en) * 2006-06-29 2016-10-13 Fred Wood Apparatus-Mounted Vein Contrast Enchancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2626260A (en) * 1951-09-05 1953-01-20 Sterling Drug Inc Nitrobenzisoxazoles
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US4021552A (en) * 1975-06-27 1977-05-03 A. H. Robins Company, Incorporated 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES
US4327103A (en) * 1980-07-07 1982-04-27 Hoechst-Roussel Pharmaceuticals Incorporated 3-{3-[4-(4-Fluorobenzoyl)piperidyl]propyl}-2-methyl indole
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
IL66866A (en) * 1982-04-09 1987-08-31 Hoechst Roussel Pharma 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
JPS61219950A (ja) * 1985-03-26 1986-09-30 Fuji Photo Film Co Ltd 熱現像感光材料
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
EP0200444B1 (en) * 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
FR2616149B1 (fr) * 1987-06-04 1990-10-19 Adir Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
DE3827253A1 (de) * 1987-08-20 1989-03-02 Sandoz Ag Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5114936A (en) * 1990-08-23 1992-05-19 Hoechst-Roussel Pharmaceuticals Incorporated 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use

Also Published As

Publication number Publication date
IL101700A (en) 1995-11-27
AU1518792A (en) 1992-11-05
PL168870B1 (pl) 1996-04-30
HU9201414D0 (en) 1992-07-28
JPH05132472A (ja) 1993-05-28
ES2094843T3 (es) 1997-02-01
GR3021211T3 (en) 1996-12-31
HUT62889A (en) 1993-06-28
PL168090B1 (pl) 1996-01-31
FI921875A0 (fi) 1992-04-27
EP0511610A1 (en) 1992-11-04
MX9201963A (es) 1992-11-01
NO180488C (no) 1997-04-30
NO180488B (no) 1997-01-20
KR920019784A (ko) 1992-11-20
DE69213544D1 (de) 1996-10-17
NO921654L (no) 1992-10-30
ATE142628T1 (de) 1996-09-15
JP2656189B2 (ja) 1997-09-24
NZ242479A (en) 1995-02-24
CA2067404A1 (en) 1992-10-30
CS129892A3 (en) 1992-11-18
KR100215345B1 (ko) 1999-08-16
US5143923B1 (en) 1993-11-02
DK0511610T3 (cs) 1997-06-16
AU644054B2 (en) 1993-12-02
FI921875A7 (fi) 1992-10-30
RU2039057C1 (ru) 1995-07-09
PL294358A1 (en) 1993-08-09
IE77036B1 (en) 1997-11-19
DE69213544T2 (de) 1997-02-27
HU214032B (en) 1997-12-29
EP0511610B1 (en) 1996-09-11
IE921379A1 (en) 1992-11-04
US5143923A (en) 1992-09-01
IL101700A0 (en) 1992-12-30
NO921654D0 (no) 1992-04-28
CZ282764B6 (cs) 1997-10-15
CA2067404C (en) 2003-08-19

Similar Documents

Publication Publication Date Title
FI921875L (fi) Foerfarande foer framstaellning av bensisotiazol- och bensisoxazol-3-karboxamider, vilka aer anvaendbara som laekemedel
FI925167A0 (fi) 2-substituerade sackarinderivat, som aer inhibitorer foer proteolytiska enzymer
FI925802L (fi) Hyaluronsyraderivat, som aer oloesliga i vatten
FI922222A7 (fi) Kopplingsanordning, som foermaor laosa spinalosteosyntesfaestanordningar
FI925615L (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening
FI932443L (fi) Koncentrat, som aer laempliga foer framstaellning av funktionaliserade polyolefiner, och funktionaliseringsprocess, daer dessa koncentrat anvaends
FI905513A0 (fi) Kombinationer av foereningar isolerade fraon gurkmeja-arter, vilka aer anvaendbara som anti-inflammatoriska aemnen.
FI935299L (fi) Doseringsmedel, som aer foersett med en baerarvaetskemembran
FI931278L (fi) Polymerer, som innehaoller sulfogrupper
FI923281L (fi) Foerbaettrade desinfektionsloesningar, som innehaoller vaeteperoxid
FI932527L (fi) Anvaendning av polypropylenglykol saosom tillsatsaemne, som reducerar krympningens storlek i dispersionspulversammansaettningar avsedda foer byggmaterialer
FI922235L (fi) Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet
FI921073L (fi) Kompositioner, vilka aer laempliga som bindemedel och skyddsbelaeggningarfoer tryckfaerger
FI905663A7 (fi) Foerfarande foer erhaollande av pyridazinderivat, vilka aer anvaendbara som lignder av acetylkolinaktiga receptorer.
FI910425L (fi) Di- och tetrafluoranaloger av skvalen som skvalenepoxidas-inhibitorer.
FI914201L (fi) Anvaendning av staerkelseblandningar som puddingstaerkelse.
FI914453A7 (fi) Foerfarande foer kompressering av en videobild, som kodats digitaliskt
FI932009L (fi) Katalytsystem som aer anvaendbart i stereospecifik polymerisering av a-olefiner, polymerisationsfoerfarande och erhaollna polymerer
FI924572A7 (fi) Foerfarande foer koer- och bromsreglering av fordon, vilka aer foersedda med flera enkelraddrifts- och bromsmoduler
FI911720L (fi) Anvaendning av makrocykliska foereningar som komponenter foer ferroelektriska vaetskekristallblandningar.
FI912287A0 (fi) Anvaendning av heminnehaollande proteiner som stabilisatorer foer enzymmaerkta immunreaktanter.
FI915508L (fi) Foerfarande foer framstaellning av en torrfoderblandning, som aer laemplig foer framstaellning av vaotfoder foer husdjur.
FI890415A0 (fi) Foerfarande foer framstaellning av substituerade imidazolinfoereningar, vilka aer anvaendbara som textilbehandlingsmedel.
FI902885A0 (fi) Hoegfrekvensfoerstaerkare som aer foerdubblad med hetberedskapsmetoden.
FI914502A7 (fi) Foerfarande foer framstaellning av goedselgran goedselgranuler som aer svarloesliga i vatten.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL, INC.

MA Patent expired